Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia

NCT03024086 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

124

Enrollment

INDUSTRY

Sponsor class

Conditions

Functional Dyspepsia

Interventions

DRUG: DWJ1252
DRUG: Gasmotin

Sponsor

Daewoong Pharmaceutical Co. LTD.